CXCL12 genetic variants as prognostic markers in nasopharyngeal carcinoma

References

• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin201161699021296855
   PubMed Web of Science ®Google Scholar
• KamMKTeoPMChauRMTreatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experienceInt J Radiat Oncol Biol Phys2004601440145015590175
   PubMed Web of Science ®Google Scholar
• ChenLMaoYPXieFYThe seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in ChinaRadiother Oncol201210433133722103978
   PubMed Web of Science ®Google Scholar
• MantovaniAAllavenaPSicaABalkwillFCancer-related inflammationNature200845443644418650914
   PubMed Web of Science ®Google Scholar
• BurgerJAKippsTJCXCR4: a key receptor in the crosstalk between tumor cells and their microenvironmentBlood20061071761176716269611
   PubMed Web of Science ®Google Scholar
• TeicherBAFrickerSPCXCL12 (SDF-1)/CXCR4 pathway in cancerClin Cancer Res2010162927293120484021
   PubMed Web of Science ®Google Scholar
• SaigusaSToiyamaYTanakaKStromal CXCR4 and CXCL12 expression is associated with distant recurrence and poor prognosis in rectal cancer after chemoradiotherapyAnn Surg Oncol2010172051205820177796
   PubMed Web of Science ®Google Scholar
• WangNWuQLFangYExpression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcomeJ Transl Med200532615978137
   PubMed Web of Science ®Google Scholar
• FedersppielBMelhadoIGDuncanAMMolecular cloning of the cDNA and chromosomal localization of the gene for a putative seven-transmembrane segment (7-TMS) receptor isolated from human spleenGenomics1993167077128325644
   PubMed Web of Science ®Google Scholar
• PetersenDCGlashoffRHShresthaSRisk for HIV-1 infection associated with a common CXCL12 (SDF1) polymorphism and CXCR4 variation in an African populationJ Acquir Immune Defic Syndr20054052152616284526
   PubMed Web of Science ®Google Scholar
• ShirozuMNakanoTInazawaJStructure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) geneGenomics1995284955007490086
   PubMed Web of Science ®Google Scholar
• WinklerCModiWSmithMWGenetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC)Science19982793893939430590
   PubMed Web of Science ®Google Scholar
• ChangSCLinPCYangSHWangHSLiAFLinJKSDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancerAnn Surg Oncol2009162323233019472013
   PubMed Web of Science ®Google Scholar
• CacinaCBulgurcuoglu-KuranSIyibozkurtACYaylim-EraltanICakmakogluBGenetic variants of SDF-1 and CXCR4 genes in endometrial carcinomaMol Biol Rep2012391225122921607621
   PubMed Web of Science ®Google Scholar
• LeeYLKuoWHLinCWAssociation of genetic polymorphisms of CXCL12/SDF1 gene and its receptor, CXCR4, to the susceptibility and prognosis of non-small cell lung cancerLung Cancer20117314715221292343
   PubMed Web of Science ®Google Scholar
• LaiSZLiWFChenLHow does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?Int J Radiat Oncol Biol Phys20118066166820643517
   PubMed Web of Science ®Google Scholar
• LeungSFZeeBMaBBPlasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinomaJ Clin Oncol2006245414541817135642
   PubMed Web of Science ®Google Scholar
• LvXXiangYQCaoSMProspective validation of the prognostic value of elevated serum vascular endothelial growth factor in patients with nasopharyngeal carcinoma: more distant metastases and shorter overall survival after treatmentHead Neck20113378078520967862
   PubMed Web of Science ®Google Scholar
• LiXJPengLXShaoJYAs an independent unfavorable prognostic factor, IL-8 promotes metastasis of nasopharyngeal carcinoma through induction of epithelial-mesenchymal transition and activation of AKT signalingCarcinogenesis2012331302130922610073
   PubMed Web of Science ®Google Scholar
• HunterKWCrawfordNPGerm line polymorphism in metastatic progressionCancer Res2006661251125416452174
   PubMed Web of Science ®Google Scholar
• TaichmanRSCooperCKellerETPientaKJTaichmanNSMcCauleyLKUse of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to boneCancer Res2002621832183711912162
   PubMed Web of Science ®Google Scholar
• SunYXSchneiderAJungYSkeletal localization and neutralization of the SDF-1 (CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivoJ Bone Miner Res20052031832915647826
   PubMed Web of Science ®Google Scholar
• ScalaSOttaianoAAsciertoPAExpression of CXCR4 predicts poor prognosis in patients with malignant melanomaClin Cancer Res2005111835184115756007
   PubMed Web of Science ®Google Scholar
• AkashiTKoizumiKTsuneyamaKSaikiITakanoYFuseHChemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancerCancer Sci20089953954218201276
   PubMed Web of Science ®Google Scholar
• LiangJJZhuSBruggemanRHigh levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinomaCancer Epidemiol Biomarkers Prev2010192598260420732965
   PubMed Web of Science ®Google Scholar
• SegawaYOdaYYamamotoHClose correlation between CXCR4 and VEGF expression and their prognostic implications in nasopharyngeal carcinomaOncol Rep2009211197120219360294
   PubMed Web of Science ®Google Scholar
• HirataHHinodaYKikunoNCXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibilityClin Cancer Res2007135056506217785557
   PubMed Web of Science ®Google Scholar
• de OliveiraKBGuembarovskiRLOdaJMCXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patientsCytokine20115526026521592819
   PubMed Web of Science ®Google Scholar
• SchimanskiCCJordanMSchlaegelFSNP rs1801157 significantly correlates with distant metastasis in CXCL12 expressing esophagogastric cancerInt J Oncol20113951552021584490
   PubMed Web of Science ®Google Scholar
• ShastryBSSNPs: impact on gene function and phenotypeMethods Mol Biol200957832219768584
   PubMedGoogle Scholar
• AlbertSRiveiroMEHalimiCFocus on the role of the CXCL12/CXCR4 chemokine axis in head and neck squamous cell carcinomaHead Neck201335121819182823468253
   PubMed Web of Science ®Google Scholar
• PeledAWaldOBurgerJDevelopment of novel CXCR4-based therapeuticsExpert Opin Investig Drugs201221341353
   PubMed Web of Science ®Google Scholar
• DiPersioJFStadtmauerEANademaneeAPlerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myelomaBlood20091135720572619363221
   PubMed Web of Science ®Google Scholar
• De ClercqEThe AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil)Biochem Pharmacol2009771655166419161986
   PubMed Web of Science ®Google Scholar
• HotteSJHirteHWMorettoPFinal results of a phase I/II study of CTCE-9908, a novel anticancer agent that inhibits CXCR4, in patients with advanced solid cancersEur J Cancer20086127
   Web of Science ®Google Scholar